Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esomeprazole for Gastric Emptying in Functional Dyspepsia
NCT00951431Phase 4Completed
- Sponsor
- The Chinese University of Hong Kong
- Start
- Dec 2009
- Primary completion
- Dec 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of esomeprazole in functional dyspepsia (FD) (2 arms), sponsored by The Chinese University of Hong Kong. Primary endpoint: Gastric emptying rate as measured by BreathID: Area-under-curve (AUC) values and half-emptying time (t1/2) at 8 weeks. Started Dec 2009; status: completed.
02
Drugs
esomeprazole
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT00951431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00951431.